Parity, age at first birth, and risk of death from chronic renal failure: a cohort study of parous women in Taiwan.

Abstract:

BACKGROUND:This study was undertaken to examine whether there is an association between parity and age at first birth and risk of death from chronic renal failure (CRF). STUDY DESIGN:Prospective cohort study. SETTING AND PARTICIPANTS:The study cohort consisted of 1 292 462 women who had a first and singleton childbirth between January 1, 1978 and December 31, 1987. We tracked each woman from the time of their first childbirth to December 31, 2009, and their vital status was ascertained by linking records with the computerized mortality database. PREDICTORS:Parity and age at first birth. OUTCOME:Death of chronic renal failure (CRF). RESULTS:There were 225 CRF deaths during 34 980 246 person-years of follow-up. The mortality rate of CRF was 0.64 cases per 100 000 person-years. Adjusted hazard ratios (HRs) were 1.75 (95% CI= 1.30-2.36) for women who gave birth between 26 and 30 years, 2.52 (95% CI=1.57-4.04) for women who gave birth after 30 years, respectively, when compared with women who gave birth younger than 25 years. Adjusted HRs were 0.47 (95% CI= 0.33-0.66) for women who had two children, and 0.40 (95% CI=0.28-0.58) for women with three or more births, respectively, when compared with women who had given birth to only one child. There was a significant decreasing trend in the HRs of CRF death with increasing parity. CONCLUSIONS:This study provides evidence that reproductive factors (parity and early age at first birth) may confer a protective effect on the risk of CRF death.

journal_name

J Nephrol

journal_title

Journal of nephrology

authors

Kuo CC,Lee CT,Chen CC,Tsai SS,Yang CY

doi

10.5301/jn.5000171

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

273-80

issue

2

eissn

1121-8428

issn

1724-6059

pii

6AA74F45-4756-4B30-A16C-9406FB1702DF

journal_volume

26

pub_type

杂志文章
  • Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.

    abstract:BACKGROUND:This study is part of a 3-country study testing whether normal levels of hemoglobin (Hgb) delay the progression of left ventricular (LV) growth in chronic kidney disease (CKD) patients not on dialysis. METHODS:This was an open-label, randomized, multicenter, controlled trial conducted in 27 tertiary-care ho...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Cianciaruso B,Ravani P,Barrett BJ,Levin A,ITA-EPO-7 investigators.

    更新日期:2008-11-01 00:00:00

  • A primer on survival analysis.

    abstract::Survival analysis is the statistical method for studying the time between entry to a study and a subsequent event. Survival is often the most important outcome in both observational and intervention studies. The analysis of survival, however, is not simple because of a number of factors. The time between entry to a st...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Khan IH,Prescott GJ

    更新日期:2004-03-01 00:00:00

  • Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.

    abstract:BACKGROUND AND AIMS:This study aimed to test the hypothesis that visfatin is associated with atherosclerosis in patients with chronic kidney disease (CKD). METHODS:In the study, we measured serum triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol lev...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.2010.3488

    authors: Mu J,Feng B,Ye Z,Yuan F,Zeng W,Luo Z,Qi W

    更新日期:2011-03-01 00:00:00

  • Clinical and therapeutic aspects of diabetic nephropathy.

    abstract:UNLABELLED:The prognosis of renal survival in both type 1 and type 2 diabetes mellitus is not benign. Several factors characterize the increase in the risk of developing renal damage in diabetic patients, distinguished in diabetes-related factors, genetic factors and other factors. DIAGNOSIS:Diagnosis requires standar...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Strippoli GF,Di Paolo S,Cincione R,Di Palma AM,Teutonico A,Grandaliano G,Schena FP,Gesualdo L

    更新日期:2003-07-01 00:00:00

  • Rapidly progressive glomerulonephritis.

    abstract::The management of rapidly progressive glomerulonephritis has been transformed over the past thirty years. It has become one of the few forms of glomerulonephritis that can be effectively treated, and today overall renal survival is as high as 70%. Effective management of patients with RPGN requires prompt and accurate...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Erwig LP,Rees AJ

    更新日期:1999-07-01 00:00:00

  • Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

    abstract:INTRODUCTION:Medullary cystic kidney disease type 1 (MCKD1; OMIM #174000) is a familial progressive tubule-interstitial nephropathy belonging to the recently defined group of autosomal dominant tubulointerstitial kidney diseases (ADTKD). CASE REPORT:A specific type of cytosine insertion in the extracellular variable n...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0282-9

    authors: Musetti C,Babu D,Fusco I,Mellone S,Zonta A,Quaglia M,Cantaluppi V,Stratta P,Giordano M

    更新日期:2016-06-01 00:00:00

  • Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.

    abstract:BACKGROUND:Early initiation of therapy is warranted for patients with idiopathic membranous nephropathy (IMN) who have severe proteinuria. Therapy with tacrolimus (TAC) or intravenous cyclophosphamide (CYC) may be an option in treating such patients. METHODS:This prospective cohort study included patients with IMN who...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章

    doi:

    authors: Li X,Lv R,He Q,Li H,Du X,Lin W,Li Q,He X,Wang S,Chen J

    更新日期:2008-07-01 00:00:00

  • Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.

    abstract::Nephrogenic systemic fibrosis (NSF) / nephrogenic fibrosing dermopathy (NFD) is a recently described disease, occurring only in patients with variable degrees of renal failure (RF) previously exposed to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging. Public advisories are consistent on some ke...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Canavese C,Mereu MC,Aime S,Lazzarich E,Fenoglio R,Quaglia M,Stratta P

    更新日期:2008-05-01 00:00:00

  • Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?

    abstract::The partial correction of anemia and the normalization of phosphate and blood pressure are the mainstay of treatment of patients with chronic kidney disease (CKD). Available anti-hypertensive drugs, erythropoiesis stimulating agents (ESAs) and iron supplements have resolved quite satisfactorily the goal of controlling...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-017-0421-y

    authors: Locatelli F,Del Vecchio L

    更新日期:2017-12-01 00:00:00

  • Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.

    abstract:BACKGROUND:Chronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0291-8

    authors: Roggeri A,Roggeri DP,Zocchetti C,Bersani M,Conte F,ReNe (Renal Lombardy Network).,Additional contributors from ReNe Network.

    更新日期:2017-04-01 00:00:00

  • Complicated pregnancies in inherited distal renal tubular acidosis: importance of acid-base balance.

    abstract::Inherited distal renal tubular acidosis (dRTA) is caused by impaired urinary acid excretion resulting in hyperchloremic metabolic acidosis. Although the glomerular filtration rate (GFR) is usually preserved, and hypertension and overt proteinuria are absent, it has to be considered that patients with dRTA also suffer ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0370-x

    authors: Seeger H,Salfeld P,Eisel R,Wagner CA,Mohebbi N

    更新日期:2017-06-01 00:00:00

  • Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients.

    abstract:BACKGROUND:Chronotropic incompetence (CI) is an independent predictor of cardiovascular events and overall mortality. The prevalence and significance of CI in renal transplant patient has not been examined. METHODS:38 non-heart failure renal transplant recipients were recruited for a transthoracic echocardiogram and t...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0091-y

    authors: Ma MK,Zuo ML,Yap DY,Mok MM,Kwan LP,Chan GC,Siu DC,Chan TM

    更新日期:2014-08-01 00:00:00

  • Determinants and survival implications of low bone mineral density in end-stage renal disease patients.

    abstract:BACKGROUND:Reduced bone mineral density (BMD) is common in end-stage renal disease (ESRD) patients and predicts outcomes. The chronic kidney disease-mineral bone disorder contributes to low BMD in ESRD; however, the impact of classical risk factors for osteoporosis in the general population, such as body weight and fat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000185

    authors: Park SH,Jia T,Qureshi AR,Bárány P,Heimbürger O,Larsson TE,Axelsson J,Stenvinkel P,Lindholm B

    更新日期:2013-05-01 00:00:00

  • Role of tubulointerstitial plasmin in the progression of IgA nephropathy.

    abstract:BACKGROUND:Plasmin has recently been reported to be associated with renal fibrosis in experimental models, but its role in human renal diseases is unclear. METHODS:Fifty-seven patients with IgA nephropathy (IgAN) were evaluated retrospectively. Plasmin in their renal biopsy tissues was assessed by in situ zymography u...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-015-0205-1

    authors: Uchida T,Oda T,Takechi H,Matsubara H,Watanabe A,Yamamoto K,Oshima N,Sakurai Y,Kono T,Shimazaki H,Tamai S,Kumagai H

    更新日期:2016-02-01 00:00:00

  • Antiproteinuric effect of olmesartan in patients with IgA nephropathy.

    abstract:BACKGROUND:IgA nephropathy is one of the most common primary glomerulonephritides, and the clinical course of almost 40% of the patients progresses to end-stage renal disease (ESRD) within 20 years. Angiotensin-converting enzyme (ACE) inhibitors and/ or angiotensin II receptor blockers (ARBs) induce a marked renoprotec...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Tomino Y,Kawamura T,Kimura K,Endoh M,Hosoya T,Horikoshi S,Utsunomiya Y,Yasuda T,Toyoda M,Tsuge T,Kaneko K

    更新日期:2009-03-01 00:00:00

  • Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.

    abstract::The metabolic syndrome is a cluster of cardiometabolic alterations at least partly dependent on reduced insulin sensitivity and hyperinsulinemia that can have several renal implications. A systematic review and meta-analysis of studies available in the international literature in English language demonstrates that the...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s40620-014-0085-9

    authors: Rendina D,De Filippo G,D'Elia L,Strazzullo P

    更新日期:2014-08-01 00:00:00

  • Pericarditis in uremic patients: serum albumin and size of pericardial effusion predict drainage necessity.

    abstract:BACKGROUND:Pericardial effusion in uremic patients (UPE) was first described by R. Bright in 1836. It is generally agreed that patients require emergency pericardial drainage when tamponade signs are present, but in patients with no tamponade the optimal timing for drainage remains unclear. METHODS:To define patients ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0107-7

    authors: Bataille S,Brunet P,Decourt A,Bonnet G,Loundou A,Berland Y,Habib G,Vacher-Coponat H

    更新日期:2015-02-01 00:00:00

  • Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations.

    abstract::Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play a central role. The...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00803-3

    authors: Leoncini G,Viazzi F,De Cosmo S,Russo G,Fioretto P,Pontremoli R

    更新日期:2020-10-01 00:00:00

  • Haemoglobinuria for the early identification of aHUS relapse: data from the ItalKId-HUS Network.

    abstract:BACKGROUND:Atypical haemolytic uremic syndrome (aHUS) is at high risk of relapse at any time, therefore patients require lifelong monitoring. The most appropriate way to monitor patients is not yet clear. Patients could be monitored for relapse by urine dipstick testing for haemoglobinuria based on the hypothesis that ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-021-00965-8

    authors: Brambilla M,Ardissino G,Paglialonga F,Testa S,Capone V,Montini G

    更新日期:2021-01-18 00:00:00

  • News from the cyst: insights into polycystic kidney disease.

    abstract::Autosomal recessive and autosomal dominant polycystic kidney disease (ADPKD and ARPKD) are 2 major variants of inherited diseases leading to the cystic degeneration of the kidney and other organs. Primary cilia have moved into the focus of research as it is becoming increasingly clear that dysfunction of this special ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Wagner CA

    更新日期:2008-01-01 00:00:00

  • IgA nephropathy in cystic fibrosis.

    abstract::The kidney does not usually present specific lesions in cystic fibrosis (CF), although in recent years renal involvement has been reported, particularly amyloidosis and immune complex glomerulonephritis. IgA nephropathy is rare. We report four cases of IgA nephropathy out of five renal biopsies performed in the last t...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Stirati G,Antonelli M,Fofi C,Fierimonte S,Pecci G

    更新日期:1999-01-01 00:00:00

  • Increasing relevance of donor-specific antibodies in antibody-mediated rejection.

    abstract::One of the major concerns in organ transplantation is the early detection of humoral rejection, through improved diagnostic and prognostic biomarkers. Long-term survival of renal allografts is significantly lower in recipients developing donor-specific anti-HLA antibodies (DSAs) either pretransplant or posttransplant....

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000240

    authors: Zito A,Schena A,Grandaliano G,Gesualdo L,Schena FP

    更新日期:2013-03-01 00:00:00

  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.

    abstract::The most common cause of liver disease worldwide is now non-alcoholic fatty liver disease (NAFLD). NAFLD refers to a spectrum of disease ranging from steatosis to non-alcoholic steatohepatitis, causing cirrhosis, and ultimately hepatocellular carcinoma. However, the impact of NAFLD is not limited to the liver. NAFLD h...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00751-y

    authors: Kanbay M,Bulbul MC,Copur S,Afsar B,Sag AA,Siriopol D,Kuwabara M,Badarau S,Covic A,Ortiz A

    更新日期:2020-05-21 00:00:00

  • Marcello Malpighi and his academic opponents in Bologna.

    abstract::Marcello Malpighi was born in Crevalcore on March 10, 1628 and died in Rome on July 25, 1694. In Bologna he had among his opponents Giovanni Gerolamo Sbaraglia and Paoli Mini who prevented him being appointed to the chair of anatomy. This paper describes the reasons for this long term debate. ...

    journal_title:Journal of nephrology

    pub_type: 传,历史文章,杂志文章

    doi:

    authors: Campieri C,Persici E,Stefoni S

    更新日期:2004-07-01 00:00:00

  • Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage.

    abstract::The pathogenetic role of adiponectin (ADPN) in kidney failure is not yet elucidated, since in vitro and in vivo studies have demonstrated that ADPN exerts both anti-inflammatory and pro-inflammatory effects. Starting from our previous findings demonstrating that HK-2 cells express and secrete ADPN, in this study we in...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-015-0220-2

    authors: Perri A,Vizza D,Lupinacci S,Toteda G,De Amicis F,Leone F,Gigliotti P,Lofaro D,La Russa A,Bonofiglio R

    更新日期:2016-04-01 00:00:00

  • Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.

    abstract:OBJECTIVE:It is uncertain whether increasing 25-hydroxyvitamin D (25-D) levels in chronic kidney disease (CKD) patients above those recommended by current guidelines result in progressive amelioration of secondary hyperparathyroidism. Our objective was to identify a potential therapeutic 25-D target which optimally low...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s40620-015-0186-0

    authors: Ennis JL,Worcester EM,Coe FL,Sprague SM

    更新日期:2016-02-01 00:00:00

  • Inadvertent sodium loading with renal replacement therapy in critically ill patients.

    abstract:BACKGROUND:Inadvertent sodium (Na(+)) flux may occur during renal replacement therapy (RRT) in ICU. The objective of this study was to estimate sodium flux during RRT. METHODS:Between September 2011 to December 2012 we studied 60 ICU patients receiving extended daily dialysis (EDD, Fresenius 4008S) or continuous renal...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0041-8

    authors: Bihari S,Taylor S,Bersten AD

    更新日期:2014-08-01 00:00:00

  • Effects of intradialytic aerobic exercise on hemodialysis patients: a systematic review and meta-analysis.

    abstract:OBJECTIVE:Intradialytic exercise (IDE) is not yet a routine practice for hemodialysis patients, the lack of guidelines supporting it being a major reason. This systematic review and meta-analysis of aerobic IDE interventions examined the efficacy of IDE regarding quality of life (QOL), serum phosphorus, dialysis effici...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,meta分析

    doi:10.1007/s40620-018-00565-z

    authors: Salhab N,Karavetian M,Kooman J,Fiaccadori E,El Khoury CF

    更新日期:2019-08-01 00:00:00

  • What is the role of ambulatory BP monitoring in pediatric nephrology?

    abstract::Ambulatory blood pressure monitoring (ABPM) has been developed to overcome recognized deficiencies and inaccuracies of classic (office) BP measurements in the diagnosis and management of hypertension (HTN). Although in adults it has become a valuable tool for the diagnosis and ongoing management of HTN, and its use ha...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Gavrilovici C,Goldsmith DJ,Reid C,Gubeth-Tatomir P,Covic A

    更新日期:2004-09-01 00:00:00

  • Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial.

    abstract::Although several in vitro studies and clinical observations suggest that ACE-inhibitors (ACE-I) are a promising treatment for IgA nephropathy (IgAN), meta-analysis of published data is not yet conclusive. Therefore, a European double-blinded, prospective, randomized therapeutic trial was designed to evaluate ACE-I tre...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Coppo R,Chiesa M,Peruzzi L,Amore A

    更新日期:2001-11-01 00:00:00